Clinical Trial Update: Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy

View source ↗

Summary

Clinical trial update describing gene expression analyses in patients with metastatic prostate cancer treated with a CYP-17 inhibitor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• CYP-17 inhibitor therapy (CYP17 inhibitor)

Snippet

Sponsor: Mayo Clinic | Conditions: Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma | Status: ACTIVE_NOT_RECRUITING